A Comparative Study of the Effects of QS-M Needle Free Injector and Glargine Pen Subcutaneous Injection of Insulin Glargine on Insulin Use
NCT03420040
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
65
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DEVICE:
QS-M Needle Free Injector
DEVICE:
Glargine pen
Sponsor
Xijing Hospital